Related references
Note: Only part of the references are listed.Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis
Sarah F. Ackley et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval
Bishal Gyawali et al.
JAMA INTERNAL MEDICINE (2019)
Is the number of cancer drug approvals a surrogate for regulatory success?
Bishal Gyawali et al.
JOURNAL OF CANCER POLICY (2019)
A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics A Review
Julia A. Beaver et al.
JAMA ONCOLOGY (2018)
Accelerated Approval and Expensive Drugs - A Challenging Combination
Walid F. Gellad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Strength of Association Between Surrogate End Points and Survival in Oncology A Systematic Review of Trial-Level Meta-analyses
Vinay Prasad et al.
JAMA INTERNAL MEDICINE (2015)
Share Paper
